Civica signs supply agreement for medicine, after hospitals ration use

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Nordroden)
(Image: Getty/Nordroden)

Related tags: Sodium bicarbonate, Civica RX, Exela Pharma Sciences, Xelia Pharmaceuticals, Hikma Pharmaceuticals

Civica agrees a deal with Exela to secure the supply of sodium bicarbonate injections to distribute through its hospital network due to ‘ongoing shortages’.

According to the partners, sodium bicarbonate injection had been in critically short supply across US hospitals and the newly announced deal​ will work to rectify this within Civica Rx’s hospital network.

Hospitals within Civica’s network prioritized the medicine, after having to ration its use due to ongoing shortages, the non-profit organization stated.

Sodium bicarbonate injection is used to treat metabolic aciodisis, which can occur through kidney disease, cardiac arrest, diabetes, and circulatory insufficiency.

Exela Pharma Sciences received approval from the US Food and Drug Administration (FDA) for the manufacture of the product on June 20, 2019. According to the companies, the first hospitals within Civica’s network will receive the product this year.

Martin VanTrieste, CEO of Civica Rx, said, “Sodium bicarbonate is a medicine that is a staple on hospital crash carts and often used for emergency resuscitations. No hospital or patient should ever have to go without it.”

In March 2019, the number of hospitals in Civica’s network reached over 800​, with the non-profit aiming to provide its members with a secured supply of generic medication that had suffered from low levels of supply. In its latest release, Civica confirmed that it now represents over 1,000 US hospitals.

Already this year, the organization has announced a deal with Xelia Pharmaceuticals​ for the manufacture of antibiotics and with Hikma Pharmaceuticals​ for a further 14 essential sterile injectable medicines.

As a result of this latest agreement, Civica holds 17 medicines deemed in short supply within its portfolio.

Related news

Show more

Related products

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Follow us


View more